Bioinformatics imaginaries in the engine-room of genomic health policy
integration and heterogeneity in India and the UK
Bioinformatics comprises a diffuse field of technologies, knowledges, databases and software for medical and pharmaceutical innovation. It is becoming a major target of policymaking for global health goals, but experiences conflicts including over ownership and access; national versus commercial agendas; disease targeting; genomic versus clinical data. The paper draws on the political economy of states, and the performativity of policy and ‘sociotechnical imaginaries’ to identify diverging framings and imaginaries in a comparison of India and the UK. It argues that bioinformatics policies are diversified in India and increasingly co-ordinated in the UK; integration of clinical with genomic data is more prominent in the UK and more geared to hegemonic ‘platform’ technologies; India has more nation-focused, societal policy in disease strategies, and notable heterogeneity in the social production of genomic knowledge. The paper develops STS concepts by linking them to political state theory, highlighting social heterogeneity in technoscientific innovation.
Årdal C, Røttingen J-A (2012) Open Source Drug Discovery in Practice: A Case Study. PLoS Neglected Tropical Diseases 6(9): e1827. doi:10.1371/journal.pntd.0001827
Banerjee M (2011) Is pharmacogenomics a reality? Challenges and oppurtunities for India. Indian J Human Genetics, 17(Suppl 1): S1–S3. doi: 10.4103/0971-6866.80350
Baren-Nawrocka J v. (2013) The bioinformatics of genetic origins: how identities become embedded in the tools and practices of bioinformatics. Life Sciences, Society and Policy 9: 7.
Benjamin R (2009) A lab of their own: genomic sovereignty as postcolonial science policy. Policy and Society 28: 341-355.
Beuma K, Bhattacharya S (2013) Emerging technologies in India: Developments, debates and silences about nanotechnology. Science & Public Policy 40(5): 628-643.
Brahmach, OSDD Director. (undated) speech/presentation video. Available at: https://www.youtube.com/watch?v=L806P3CsxGE (accessed 7.7.2016)
Chang J, Zhu X (2010) Bioinformatics databases: intellectual property protection strategy. Journal of Intellectual Property Rights 15: 447-454.
DBT (Department of Biotechnology, India) (2011). Bioinformatics. Report. New Delhi.
Daar AS, Thorsteinsdottir H, Martin DK, Smith AC, Nast S, Singer PA (2002) Top ten biotechnologies for improving health in developing countries. Nature Genetics 32(2):229-232.
Etzkowitz H. (2008) The Triple Helix: University-Industry-Government Innovation in Action. London: Routledge.
European Society for Translational Medicine (2014) Translational Medicine definition by the European Society for Translational Medicine. New Horizons in Translational Medicine 2(3): 86–88. doi:10.1016/j.nhtm.2014.12.002
Faulkner A (2009) Regulatory policy as innovation: constructing rules of engagement of a technological zone for tissue engineering in the European Union. Research Policy 38(4): 637-646.
Faulkner A (2012) Law’s performativities: shaping the emergence of regenerative medicine through European Union legislation. Social Studies of Science 42: 753-774.
Fears R, Poste G (1999) Building population genetics resources using the UK NHS. Science 284(5412): 267-268.
Felt U (2014) Sociotechnical imaginaries of “the internet”, digital health information and the making of citizen-patients. In: Hilgartner S, Miller C, Hagendijk R (eds) Science and Democracy: Making Knowledge and Making Power in the Biosciences and Beyond. London/New York: Routledge. Preprint available at http://sts.univie.ac.at/publications. (Accessed 10.10.2016).
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D. and Bray F. (2015) Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 136: E359–E386. doi:10.1002/ijc.29210
Gates W (2009) Bill Gates Keynote – Carnegie-Mellon University. Available at: http://www.gatesfoundation.org/Media-Center/Speeches/2009/09/Bill-Gates-Carnegie-Mellon-University (accessed 10.10.2016).
Genomics England (2016) Research in the 100,000 Genomes Project. Available at:
https://www.genomicsengland.co.uk/ about-gecip/ (accessed 10.10.2016).
Gee JP (2014) An Introduction to Discourse Analysis: theory and method. 4th edition, Abingdon: Routledge.
GeneWatch UK (2015) Data Protection or exploitation? The erosion of safeguards for health and genetic research. Available at: http://www.genewatch.org/uploads/f03c6d66a9b354535738483c1c3d49e4/Data_Protection_or_exploitation_fin.pdf (accessed 21.1.2016).
Goodall S, Janssens B, Wagner K, Wong J, Woods W, Yeh M (2006) The promise of the East: India and China as R & D options. Nature Biotecnology 24(9): 1064.
Hardy B-J, Séguin B, Goodsaid F, Jimenez-Sanchez G, Singer PA, Daar AS.(2008) Nature Reviews Genetics – Genomic medicine in developing countries. October 2008 s23. doi:10.1038/nrg2379
Harvey M, McMeekin A (2002) UK Bioinformatics: Current Landscapes and Future Horizons. London: Department of Trade and Industry.
Harvey M, McMeekin A (2005) Brazilian genomics and bioinformatics: instituting new innovation pathways in a global context, Economy and Society 34(4): 634-658, DOI: 10.1080/03085140500277260
Harvey M, McMeekin A (2009) Public or private economies of knowledge: The economics of diffusion and appropriation of bioinformatics tools. International Journal of the Commons, North America 4(1):.481–506.
Hay C (2004) Re-stating politics, re-politicising the state: neo-liberalism, economic imperatives and the rise of the competition state. Political Quarterly 75(1): 38-50.
Hirsch J (1991) From the Fordist to the post-Fordist state. In: Jessop B (ed) The politics of flexibility: restructuring state and industry in Britain, Germany and Scandinavia. Aldershot: Edward Elgar.
Howard K (2000) The bioinformatics gold rush. Scientific American 283(1): 58-63.
Jasanoff S (2004) States of knowledge: co-production of science and social order. Routledge, London.
Jasanoff S (2015) Future Imperfect: Science, Technology and the Imaginations of Modernity. In: Jasanoff S, Kim S-H (eds) Dreamscapes of Modernity: Sociotechnical Imaginaries and the Fabrication of Power. Chicago: University of Chicago Press, pp1-33.
Jasanoff S , Kim S-H (2009) Containing the Atom: Sociotechnical Imaginaries and Nuclear Power in the United States and South Korea. Minerva 47(2): 119-146.
Jasanoff S, Kim S-H (2013) Sociotechnical Imaginaries and National Energy Policies. Science as Culture 22(2):189-196.
Jasanoff S, Kim S-H (2015) (eds) Dreamscapes of Modernity: Sociotechnical Imaginaries and the Fabrication of Power. University of Chicago Press.
Kale D, Little S (2007) From imitation to innovation: the evolution of R&D capabilities and learning processes in the Indian pharmaceutical industry. Technology Analysis and Strategic Managemen, 19 (5): 589–609.
Kerr A (2003) Governing genetics: Reifying choice and progress. New Genetics & Society 22(2): 143-158.
Kim YT (1999) Neoliberalism and the decline of the developmental state. Journal of Contemporary Asia 29(4): 441-62.
Lee K, Kamradt-Scott A (2014) The multiple meanings of global health governance: a call for conceptual clarity. Globalization and Health 14: 10-28. doi: 10.1186/1744-8603-10-28
Leonelli S (2014). What Difference Does Quantity Make? On the Epistemology of Big Data in Biology. Big Data and Society 1 (1): 1-11.
Lewis J, Bartlett A (2013) Inscribing a discipline: tensions in the field of Bioinformatics. New Genetics and Society 32(3): 243–263.
Mackenzie A (2003) Bringing sequences to life: how bioinformatics corporealizes sequence data. New Genetics and Society 22 (3): 315-332.
Martin P, Hollin G. (2014) A new model of innovation in biomedicine? Nuffield Council on Bioethics. Available at: http://nuffieldbioethics.org/wp-content/uploads/A-New-Model-of-Innovation_web.pdf. (accessed 15.11.2015).
McNally R, Glasner P (2006) Transcending the genome? Studying life in the proteomic bioscape, in Glasner P & Atkinson P (eds) New Genetics, New Social Formations. London: Routledge.
Meekings KN, Williams CSM, Arrowsmith JE (2012) Orphan drug development: an economically viable strategy for biopharma R&D. Drug Discovery Today 17(13/14): 660-664.
Nuffield Council on Bioethics (2015) The collection, linking and use of data in biomedical research and health care: ethical issues. Available at: http://nuffieldbioethics.org/project/biological-health-data/ (accessed 15.1.2016).
Parker M (2013) (Letter to Government’s Chief Medical Officer about Genomics England Ethics Working Group)) Available at: http://www.genomicsengland.co.uk/wp-content/uploads/2013/06/GenomicsEngland_EthicsWorkingGroup.pdf (accessed 15.11.2015).
Parveen J (2010) India step closer to personalized medicine. Biospectrum 7 October 2010. Available at: http://www.biospectrumindia.com/biospecindia/news/157500/india-steps-closer-personalized-medicine (accessed 15.11.2015)
Peplow M (2016) The 100,000 Genomes Project. British Medical Journal,353:i1757-9.
Public Health England (2016). Tuberculosis in England, 2016 Report. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/555343/TB_Annual_Report_2016_GTW2309.pdf (accessed 10.10.2016).
RNCOS (2012) Indian Bioinformatics Market Forecast to 2015. RNCOS:Noida, India.
Rhodes RAW (1996) The new governance: governing without government. Political Studies 44(4): 652-667
Salter B, Faulkner A (2011) State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding ‘Rising Powers’ in the global context. Globalization and Health 7:3.
Salter B, Faulkner A, Hogarth S (2012) Research summary ‘State strategies of governance in global biomedical innovation: the impact of China and India’. Available at: http://www.kcl.ac.uk/sspp/departments/politicaleconomy/research/Current-Research-Projects/Rising-Powers/rising-powers-II/Rising-Powers.aspx.
Salter B, Zhou Y, Datta S, Salter C (2015) Bioinformatics and the Politics of Innovation in the Life Sciences: Science and the State in the United Kingdom, China, and India. Science, Technology and Human Values 41(5) 793-826.
Sariola S, Ravindran D, Kumar A, Jeffery R. (2015) Big-pharmaceuticalisation: Clinical trials and Contract Research Organisations in India. Social Science & Medicine 131: 239-246.
Secretary of State for Health (2009) Government Response to the House of Lords Science and Technology Committee Inquiry into Genomic Medicine. The Stationery Office: London.
Shirodkar SN (2010) National Institute of Biomedical Genomics to become operational from April 2010. Available at: http://www.nibmg.ac.in/academic/Pharmabiz_NIBMG.pdf (accessed 30.1.2017).
Sleeboom-Faulkner M, Chekar CK, Faulkner A, Heitmeyer C, Marouda M, Rosemann, A, Chaisinthop N, Chang H-C, Ely A, Kato M, Patra PK, Su Y, Sui S, Suzuki W, Zhang X (2016) Comparing national home-keeping and the regulation of translational stem cell applications: an international perspective. Social Science and Medicine 153: 240-249.
Stevens H (2013) Life Out of Sequence: A data-driven history of bioinformatics. Chicago: University of Chicago Press.
Suarez-Diaz E (2010) Making Room for New Faces: Evolution, Genomics and the Growth of Bioinformatics. History and Philosophy of the Life Sciences 32: 65–90.
Sunder Rajan K. (2006) Biocapital: The Constitution of Postgenomic Life. Durham, North Carolina: Duke University Press.
Sunder Rajan K, Leonelli S (2013) Introduction: Biomedical Trans-Actions, Postgenomics and Knowledge/Value. Public Culture: society for transnational cultural studies 25(3): 463-475.
Taylor L (2013) UK life sciences let down by poor informatics skills, experts warn. Pharma Times, March 26. Available at: http://www.pharmatimes.com/Article/13-03-26/UK_life_sciences_let_down_by_poor_informatics_skills_experts_warn.aspx (accessed 15.11.2015)
Weiss L (2000) Developmental states in transition: adapting, dismantling, innovating, not ‘normalising’. The Pacific Review 13(1): 21-55, 29.
Wu Y (2004) Rethinking the Taiwanese developmental state. The China Quarterly 177: 91-114.
Zwart H (2009) Genomics and identity: the bioinformatisation of human life. Medicine Health Care and Philosophy 12(2): 125–136.
This Science & Technology Studies website ("Site") is owned and operated by The Finnish Society for Science and Technology Studies (“Society”), PO Box 117, c/o Otto Auranen, Sepänkatu 4-8 A 16, 33230 Tampere,Finland. The Finnish Society for Science and Technology Studies and its publication Science & Technology Studies are non-profit organizations.
The Society reserves the right to change, modify, add or remove portions of these Terms and Conditions at its discretion at any time and without prior notice. Please check this page periodically for any modifications. Your continued use of this Site following the posting of any changes will mean that you have accepted the changes.Copyrights and Limitations on Use
All content in this Site, including site layout, design, images, text and other information (collectively, the "Content") is the property of The Finnish Society for Science and Technology Studies/Science & Technology Studies and is protected by copyright and other intellectual property laws, unless otherwise noted.
You may not copy, display, distribute, modify, publish, reproduce, store, transmit, create derivative works from, or sell or license all or any part of the Content, products or services obtained from this Site in any medium to anyone, except as otherwise expressly permitted under applicable law or as described in these Terms and Conditions or relevant license or subscriber agreement.
You may print or download Content from the Site for academic, your own personal, non-commercial use, provided that you keep intact all copyright and other proprietary notices. You may not engage in systematic retrieval of Content from the Site to create or compile, directly or indirectly, a collection, compilation, database or directory without prior written permission from Science & Technology Studies.
The Site may contain robot exclusion headers, and by using the Site you agree that you will not use any robots, spiders, crawlers or other automated downloading programs or devices to access, search, index, monitor or copy any Content. The harvesting of postal or email addresses from the Site for purposes of sending unsolicited or unauthorized commercial material, is prohibited. Any questions about whether a particular use is authorized and any requests for permission to publish, reproduce, distribute, display or make derivative works from any Content should be directed to the Science & Technology Studies Assistant Editor.
You may not use the services on the Site to publish or distribute any information (including software or other content) that is illegal; violates or infringes upon the rights of any other person; is abusive, hateful, profane, pornographic, threatening or vulgar; contains errors, viruses or other harmful components; or is otherwise actionable by law. Science & Technology Studies may at any time exercise editorial control over the content of any information or material that is submitted or distributed through its facilities and/or services.
You may not, without the approval of Science & Technology Studies, use the Site to publish or distribute any advertising, promotional material, or solicitation to other users of the Site to use any goods or services. For example (but without limitation), you may not use the Site to conduct any business, to solicit the performance of any activity that is prohibited by law, or to solicit other users to become subscribers of other information services. Similarly, you may not use the Site to download and redistribute public information or shareware for personal gain or use the facilities and/or services to distribute multiple copies of public domain information or shareware.Trademarks
All trademarks appearing on this Site are the property of their respective owners.Links to Other Sites
The Site may contain hyperlinks to other sites or resources that are provided solely for your convenience. Science & Technology Studies is not responsible for the availability of external sites or resources linked to the Site, and does not endorse and is not responsible or liable for any content, advertising, products or other materials on or available from such sites or resources. Transactions that occur between you and any third party are strictly between you and the third party and are not the responsibility of Science & Technology Studies. Due to the fact that Science & Technology Studies is not responsible for the availability or accuracy of these outside resources or their contents, you should review the terms and conditions and privacy policies of these linked sites, as their policies may differ from ours.
Last revised: 10 October 2012